BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hillyer P, Shepard R, Uehling M, Krenz M, Sheikh F, Thayer KR, Huang L, Yan L, Panda D, Luongo C, Buchholz UJ, Collins PL, Donnelly RP, Rabin RL. Differential Responses by Human Respiratory Epithelial Cell Lines to Respiratory Syncytial Virus Reflect Distinct Patterns of Infection Control. J Virol 2018;92:e02202-17. [PMID: 29769339 DOI: 10.1128/JVI.02202-17] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Czerkies M, Kochańczyk M, Korwek Z, Prus W, Lipniacki T. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons. J Virol 2022. [DOI: 10.1128/jvi.01341-22] [Reference Citation Analysis]
2 Baldovinos Y, Archer A, Salamanca J, Strongin RM, Sayes CM. Chemical Interactions and Cytotoxicity of Terpene and Diluent Vaping Ingredients. Chem Res Toxicol 2022. [DOI: 10.1021/acs.chemrestox.2c00218] [Reference Citation Analysis]
3 Van Royen T, Sedeyn K, Moschonas GD, Toussaint W, Vuylsteke M, Van Haver D, Impens F, Eyckerman S, Lemmens I, Tavernier J, Schepens B, Saelens X, Dutch RE. An Unexpected Encounter: Respiratory Syncytial Virus Nonstructural Protein 1 Interacts with Mediator Subunit MED25. J Virol. [DOI: 10.1128/jvi.01297-22] [Reference Citation Analysis]
4 de Groot RCA, Zhu H, Hoogenboezem T, de Bruijn ACJM, Eenjes E, ’t Jong AEJ, Belo AI, Estevão SC, Bajramovic JJ, Rottier RJ, Kool M, van Rossum AMC, Unger WWJ, Pirofski L. Mycoplasma pneumoniae Compared to Streptococcus pneumoniae Avoids Induction of Proinflammatory Epithelial Cell Responses despite Robustly Inducing TLR2 Signaling. Infect Immun. [DOI: 10.1128/iai.00129-22] [Reference Citation Analysis]
5 Qin S, Huang X, Qu S. Baicalin Induces a Potent Innate Immune Response to Inhibit Respiratory Syncytial Virus Replication via Regulating Viral Non-Structural 1 and Matrix RNA. Front Immunol 2022;13:907047. [DOI: 10.3389/fimmu.2022.907047] [Reference Citation Analysis]
6 Rajan A, Piedra F, Aideyan L, Mcbride T, Robertson M, Johnson HL, Aloisio GM, Henke D, Coarfa C, Stossi F, Menon VK, Doddapaneni H, Muzny DM, Javornik Cregeen SJ, Hoffman KL, Petrosino J, Gibbs RA, Avadhanula V, Piedra PA, Heise MT. Multiple Respiratory Syncytial Virus (RSV) Strains Infecting HEp-2 and A549 Cells Reveal Cell Line-Dependent Differences in Resistance to RSV Infection. J Virol. [DOI: 10.1128/jvi.01904-21] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
7 Chen Q, Langenbach S, Li M, Xia YC, Gao X, Gartner MJ, Pharo EA, Williams SM, Todd S, Clarke N, Ranganathan S, Baker ML, Subbarao K, Stewart AG. ACE2 Expression in Organotypic Human Airway Epithelial Cultures and Airway Biopsies. Front Pharmacol 2022;13:813087. [DOI: 10.3389/fphar.2022.813087] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
8 Khan H, Winstone H, Jimenez-Guardeño JM, Graham C, Doores KJ, Goujon C, Matthews DA, Davidson AD, Rihn SJ, Palmarini M, Neil SJD, Malim MH. TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction. PLoS Pathog 2021;17:e1009820. [PMID: 34807954 DOI: 10.1371/journal.ppat.1009820] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Czerkies M, Kochańczyk M, Korwek Z, Prus W, Lipniacki T. RSV immunizes bystander cells to IAV infection using interferons β and λ.. [DOI: 10.1101/2021.10.11.463877] [Reference Citation Analysis]
10 Pardo M, Li C, Fang Z, Levin-Zaidman S, Dezorella N, Czech H, Martens P, Käfer U, Gröger T, Rüger CP, Friederici L, Zimmermann R, Rudich Y. Toxicity of Water- and Organic-Soluble Wood Tar Fractions from Biomass Burning in Lung Epithelial Cells. Chem Res Toxicol 2021;34:1588-603. [PMID: 34033466 DOI: 10.1021/acs.chemrestox.1c00020] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
11 Davis JD, Wypych TP. Cellular and functional heterogeneity of the airway epithelium. Mucosal Immunol 2021;14:978-90. [PMID: 33608655 DOI: 10.1038/s41385-020-00370-7] [Cited by in Crossref: 31] [Cited by in F6Publishing: 33] [Article Influence: 31.0] [Reference Citation Analysis]
12 Mo S, Tang W, Xie J, Chen S, Ren L, Zang N, Xie X, Deng Y, Gao L, Liu E. Respiratory syncytial virus activates Rab5a to suppress IRF1-dependent IFN-λ production, subverting the antiviral defense of airway epithelial cells. J Virol 2021:JVI. [PMID: 33504607 DOI: 10.1128/JVI.02333-20] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
13 Wittling MC, Cahalan SR, Levenson EA, Rabin RL. Shared and Unique Features of Human Interferon-Beta and Interferon-Alpha Subtypes. Front Immunol 2020;11:605673. [PMID: 33542718 DOI: 10.3389/fimmu.2020.605673] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 16.0] [Reference Citation Analysis]
14 Gao X, Chan PKS, Lui GCY, Hui DSC, Chu IM, Sun X, Tsang MS, Chan BCL, Lam CW, Wong CK. Interleukin-38 ameliorates poly(I:C) induced lung inflammation: therapeutic implications in respiratory viral infections. Cell Death Dis 2021;12:53. [PMID: 33414457 DOI: 10.1038/s41419-020-03283-2] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 18.0] [Reference Citation Analysis]
15 Yeh L, Ivanov IE, Byrum JR, Chhun BB, Guo S, Foltz C, Hashemi E, Pérez-bermejo JA, Wang H, Yu Y, Kazansky PG, Conklin BR, Han MH, Mehta SB. uPTI: uniaxial permittivity tensor imaging of intrinsic density and anisotropy.. [DOI: 10.1101/2020.12.15.422951] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
16 Pearson H, Todd EJAA, Ahrends M, Hover SE, Whitehouse A, Stacey M, Lippiat JD, Wilkens L, Fieguth HG, Danov O, Hesse C, Barr JN, Mankouri J. TMEM16A/ANO1 calcium-activated chloride channel as a novel target for the treatment of human respiratory syncytial virus infection. Thorax 2021;76:64-72. [PMID: 33109690 DOI: 10.1136/thoraxjnl-2020-215171] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
17 Karnup SV, De Groat WC. Mapping of spinal interneurons involved in regulation of the lower urinary tract in juvenile male rats. IBRO Rep 2020;9:115-31. [PMID: 32775758 DOI: 10.1016/j.ibror.2020.07.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
18 Dissanayake TK, Schäuble S, Mirhakkak MH, Wu WL, Ng AC, Yip CCY, López AG, Wolf T, Yeung ML, Chan KH, Yuen KY, Panagiotou G, To KK. Comparative Transcriptomic Analysis of Rhinovirus and Influenza Virus Infection. Front Microbiol 2020;11:1580. [PMID: 32849329 DOI: 10.3389/fmicb.2020.01580] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
19 Broggi A, Granucci F, Zanoni I. Type III interferons: Balancing tissue tolerance and resistance to pathogen invasion. J Exp Med 2020;217:e20190295. [PMID: 31821443 DOI: 10.1084/jem.20190295] [Cited by in Crossref: 67] [Cited by in F6Publishing: 67] [Article Influence: 33.5] [Reference Citation Analysis]
20 Efstathiou C, Abidi SH, Harker J, Stevenson NJ. Revisiting respiratory syncytial virus's interaction with host immunity, towards novel therapeutics. Cell Mol Life Sci 2020;77:5045-58. [PMID: 32556372 DOI: 10.1007/s00018-020-03557-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
21 Andrade CA, Pacheco GA, Gálvez NMS, Soto JA, Bueno SM, Kalergis AM. Innate Immune Components that Regulate the Pathogenesis and Resolution of hRSV and hMPV Infections. Viruses 2020;12:E637. [PMID: 32545470 DOI: 10.3390/v12060637] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
22 Li J, Li M, Wang X, Sun M, Ma C, Liang W, Gao X, Wei L. Long Noncoding RNA NRAV Promotes Respiratory Syncytial Virus Replication by Targeting the MicroRNA miR-509-3p/Rab5c Axis To Regulate Vesicle Transportation. J Virol 2020;94:e00113-20. [PMID: 32102886 DOI: 10.1128/JVI.00113-20] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 10.0] [Reference Citation Analysis]
23 Martín-Vicente M, González-Riaño C, Barbas C, Jiménez-Sousa MÁ, Brochado-Kith O, Resino S, Martínez I. Metabolic changes during respiratory syncytial virus infection of epithelial cells. PLoS One 2020;15:e0230844. [PMID: 32214395 DOI: 10.1371/journal.pone.0230844] [Cited by in Crossref: 26] [Cited by in F6Publishing: 26] [Article Influence: 13.0] [Reference Citation Analysis]
24 Touzelet O, Broadbent L, Armstrong SD, Aljabr W, Cloutman-Green E, Power UF, Hiscox JA. The Secretome Profiling of a Pediatric Airway Epithelium Infected with hRSV Identified Aberrant Apical/Basolateral Trafficking and Novel Immune Modulating (CXCL6, CXCL16, CSF3) and Antiviral (CEACAM1) Proteins. Mol Cell Proteomics 2020;19:793-807. [PMID: 32075873 DOI: 10.1074/mcp.RA119.001546] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
25 Glaser L, Coulter PJ, Shields M, Touzelet O, Power UF, Broadbent L. Airway Epithelial Derived Cytokines and Chemokines and Their Role in the Immune Response to Respiratory Syncytial Virus Infection. Pathogens 2019;8:E106. [PMID: 31331089 DOI: 10.3390/pathogens8030106] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 8.3] [Reference Citation Analysis]
26 Aranda SS, Polack FP. Prevention of Pediatric Respiratory Syncytial Virus Lower Respiratory Tract Illness: Perspectives for the Next Decade. Front Immunol 2019;10:1006. [PMID: 31134078 DOI: 10.3389/fimmu.2019.01006] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
27 Hijano DR, Vu LD, Kauvar LM, Tripp RA, Polack FP, Cormier SA. Role of Type I Interferon (IFN) in the Respiratory Syncytial Virus (RSV) Immune Response and Disease Severity. Front Immunol 2019;10:566. [PMID: 30972063 DOI: 10.3389/fimmu.2019.00566] [Cited by in Crossref: 51] [Cited by in F6Publishing: 52] [Article Influence: 17.0] [Reference Citation Analysis]
28 Bohmwald K, Gálvez NMS, Canedo-Marroquín G, Pizarro-Ortega MS, Andrade-Parra C, Gómez-Santander F, Kalergis AM. Contribution of Cytokines to Tissue Damage During Human Respiratory Syncytial Virus Infection. Front Immunol 2019;10:452. [PMID: 30936869 DOI: 10.3389/fimmu.2019.00452] [Cited by in Crossref: 35] [Cited by in F6Publishing: 36] [Article Influence: 11.7] [Reference Citation Analysis]